Introduction Biological age reflects inter-individual differences in biological function and capacity beyond chronological age. Biological age can be estimated by DNA methylation age (DNAmA) and its deviation from chronological age, DNAmA acceleration (DNAmAA). Low levels of serum selenium, selenoprotein P (SELENOP), and the selenocysteine-containing glutathione peroxidase 3 (GPx3) are associated with adverse health outcomes and selenium supplementation is discussed as an anti-aging intervention. Methods In this study we analyzed 1,568 older participants from the Berlin Aging Study II (mean age +/- SD: 68.8 +/- 3.7 years, 51% women). DNAmA was estimated from genome-wide DNA methylation data using the Horvath, GrimAge, and DunedinPACE algorithms. Serum selenium levels were measured by total reflection X-ray fluorescence (TXRF) spectroscopy. SELENOP was measured by ELISA and GPx3 was derived from a larger set of mass spectrometry proteomics data. Results Participants with deficient serum selenium levels (<90μg/L) had a higher rate of biological aging (DunedinPACE, p=0.01, n=865). This association remained statistically significant after adjustment for age, sex, BMI, smoking, and genetic ancestry (β=-0.02, SE=0.01, 95%CI: -0.034 to -0.004, n=757). Compared to the highest quartile, participants in the lowest quartile of SELENOP levels showed an accelerated biological aging rate (DunedinPACE, β=-0.03, SE=0.01, 95%CI: -0.051 to -0.008, n=740, fully adjusted model). Similarly, after adjustment for covariates, accelerated biological age was found in participants within the lowest GPx3 quartile compared to participants in the fourth quartile (DunedinPACE, p=<0.001 and GrimAge, p<0.001). Conclusion Our study suggests that low levels of selenium biomarkers are associated with accelerated biological aging measured as DNAmA. This effect was not substantially changed after adjustment for known covariates.